ZBH NYSE
Credit Risk of going bust: lower than 59% of companies Debt: 29.0% of company value Bonds: $395.5M held by 204 funds, 69 bp over Treasuries → details ▾
If the stock fell to about $2.93 (down 97%), Zimmer Biomet Holdings, Inc. would be worth roughly what it owes.
Total debt $7.48B against a stock market value of $18.32B.
Distance to default 6.04 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.34B (short-term plus half of long-term), stock volatility 33.5%; Altman Z 2.48. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Warsaw, IN 46580
US
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Campbell Gary Craig | M-Exempt | 2,368 | — | 2026-10-01 |
| Campbell Gary Craig | F-InKind | 932 | $88.42 | 2026-10-01 |
| Campbell Gary Craig | M-Exempt | 1,218 | — | 2026-10-01 |
| Campbell Gary Craig | F-InKind | 480 | $88.42 | 2026-10-01 |
| Campbell Gary Craig | M-Exempt | 2,368 | — | 2026-10-01 |